Novel alternate hemostatic agents for patients with inhibitors: beyond bypass therapy. [PDF]
Ragni MV.
europepmc +1 more source
'These Are the Medicines That "Make" Monsters': Thalidomide in Southern Africa, 1958-1962. [PDF]
Parle J, Wimmelbücker L.
europepmc +1 more source
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation. [PDF]
Morris ZS +47 more
europepmc +1 more source
Cretaceous small scavengers: feeding traces in tetrapod bones from Patagonia, Argentina. [PDF]
de Valais S, Apesteguía S, Garrido AC.
europepmc +1 more source
Molecular targeting of papillary thyroid carcinoma with fluorescently labeled ratiometric activatable cell penetrating peptides in a transgenic murine model. [PDF]
Orosco RK +6 more
europepmc +1 more source
Thrombin activity associated with neuronal damage during acute focal ischemia. [PDF]
Chen B +10 more
europepmc +1 more source
In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity. [PDF]
Olson ES +10 more
europepmc +1 more source
Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application. [PDF]
Xie J +6 more
europepmc +1 more source
Impact of MMP-2 and MMP-9 enzyme activity on wound healing, tumor growth and RACPP cleavage. [PDF]
Hingorani DV +9 more
europepmc +1 more source
Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma. [PDF]
Raju SC +14 more
europepmc +1 more source

